Valuation: Medios AG

Market Cap 296M 338M 273M 255M 479M 31.85B 489M 3.28B 1.27B 15.74B 1.27B 1.24B 54.58B P/E 2026 *
10.9x
P/E 2027 * 8.69x
Enterprise Value 372M 424M 343M 321M 602M 40.03B 615M 4.12B 1.59B 19.78B 1.59B 1.56B 68.59B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.41%
1 week-5.18%
Current month-11.18%
1 month-10.12%
3 months+0.17%
6 months-14.57%
Current year-16.57%
1 week 11.98
Extreme 11.98
12.34
1 month 11.8
Extreme 11.8
13.88
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-5.18%-2.74%-21.86% 338M
+7.13%+9.97%+55.80%+163.38% 1,077B
+3.99%+11.50%+67.09%+56.27% 613B
+4.20%+17.03%+38.97%+91.19% 448B
+0.99%+4.85%+28.17%+22.04% 332B
+1.82%+8.19%+40.04%+27.45% 293B
+0.22%+6.75%+31.30%+42.64% 286B
+0.73%+8.53%-27.33%-40.29% 215B
+1.56%+6.14%+29.30%+61.91% 193B
+3.26%+3.33%+15.55%+67.87% 159B
Average +2.43%+7.11%+27.62%+47.06% 361.64B
Weighted average by Cap. +3.85%+9.65%+41.75%+81.01%

Financials

2026 *2027 *
Net sales 2.08B 2.37B 1.92B 1.8B 3.37B 224B 3.44B 23.06B 8.92B 111B 8.91B 8.72B 384B 2.14B 2.44B 1.97B 1.85B 3.46B 230B 3.53B 23.69B 9.17B 114B 9.16B 8.96B 394B
Net income 27.56M 31.43M 25.4M 23.78M 44.59M 2.96B 45.52M 305M 118M 1.47B 118M 115M 5.08B 34.36M 39.18M 31.67M 29.65M 55.6M 3.7B 56.75M 381M 147M 1.83B 147M 144M 6.33B
Net Debt 76M 86.68M 70.06M 65.59M 123M 8.18B 126M 842M 326M 4.04B 325M 318M 14.01B 40.72M 46.45M 37.54M 35.14M 65.9M 4.38B 67.27M 451M 175M 2.17B 174M 171M 7.51B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
26/06/26 €12.08 -0.17% 18,791
25/06/26 €12.10 -0.98% 20,352
24/06/26 €12.22 +1.16% 65,578
23/06/26 €12.08 -2.42% 21,775
22/06/26 €12.38 -2.83% 20,446
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.08EUR
Average target price
23.00EUR
Spread / Average Target
+90.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock